Intellectual Property

New article in IP Today – Staying Ahead: How Can Robust IP Protection Help Countries Prepare for the Next Ebola?

Posted by:

This week IP Today published an article by Pugatch Consilium Partner, Rachel Chu.

Looking at the race to develop the Ebola vaccine as well as other new medicines, the article draws a connection between investment in R&D, clinical trials and the protection of IPRs – all aimed at developing next generation healthcare technologies and medicines.

“Although increasing resources directed towards the health system is among the most obvious steps policymakers can take, one element often overlooked is the level of support toward ...

Continue Reading →
0

Developing a Culture of Pharmacovigilance

Posted by:

Today Pugatch Consilium launches Developing a Culture of Pharmacovigilance. Authored by Professor Meir Pugatch, Dr David Torstensson and Ma’ayan Laufer this report examines one of the most important facets of a high quality drug regulatory structure, namely that of pharmacovigilance.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span – from test tube to patient. As patients and healthcare professionals around the world access and ...

Continue Reading →
0

The Creative Industries and the BRICS – full report is now available on our site!

Posted by:

A review of the state of the creative economy in Brazil, Russia, India, China and South Africa

This review examines the state of the creative economy in the biggest emerging economies in the world namely Brazil, Russia, India, China and South Africa – the BRICS. Although at different levels of development, these economies are in many ways undergoing similar transitions from economies based on manufacturing, industrial output and natural resources to economies in which economic activity is ...

Continue Reading →
0

Dr David Torstensson speaks on clinical trials transparency at American Chamber of Commerce to the EU in Brussels

Posted by:

Pugatch Consilium Partner, Dr Torstensson presented the main findings of the Pugatch Consilium report Heading in a Different Direction? The European Medicines Agency’s Policy on the Public Release of Clinical Trials Data at the report’s EU launch. The launch took place at the AmCham EU offices in Brussels, Belgium.

The report was commissioned by the US Chamber of Commerce’s GIPC. It examines the debate and policies in place on public disclosure of clinical trials data and information in Europe, the US, ...

Continue Reading →
0

The US Chamber of Commerce and Pugatch Consilium’s Dr David Torstensson launch 2nd edition of the GIPC IP Index

Posted by:

Dr David Torstensson, Partner with Pugatch Consilium, is speaking at the international launch of the 2013 GIPC IP Index at the US Chamber of Commerce in Washington DC, USA. Pugatch Consilium has developed the GIPC IP Index in partnership with the US Chamber of Commerce’s Global Intellectual Property Center. The Index is a one-of-a-kind instrument that benchmarks and measures the national IP environment in 25 countries.

The launch of the 2013 Index will take place on January 29 2014 starting at ...

Continue Reading →
0

When National Champions Fall

Posted by:

The case of Teva requires us to revise our thinking about national champions and national interests;
Prof. Meir Perez Pugatch addresses the current situation with Teva pharmaceuticals – the biggest generics company in the world – in Israel and how it has been impacted by the patent expiration of Copaxon. Full article at Pharmaphorum Media

Continue Reading →
0
Page 4 of 7 «...23456...»